Gene Data of Basel, Switzerland, last week released two new modules for its analysis suite of products.
The firm, a 1997 spinout from Novartis, introduced Screener Condenser and Screener Analyst for its GeneData Screener system for the analysis of high-throughput screening data.
The Condenser product performs data standardization as well as data annotation. It is designed to integrate results from primary and secondary screening into bioactivity profiles.
The Analyst product is used for cross-assay compound profiling based on HTS data. It is intended for large-scale assay comparisions, biological activity profiling of compounds or compound libraries across large numbers of assays, separation of mechanisms of actions, and identification of chemical structural elements conferring a desired biological activity. The products, together, are intended to provide a data analysis workflow. They were developed in collaboration with the pharmaceutical company Altana Pharma.